Latent tuberculous infection.
Yun
Joon S
JS
Department of Medicine, Georgetown University Medical Center, Washington, DC, USA.
Lazarus
Angeline A
AA
Gilbert
Russell
R
D000904:Antibiotics, Antitubercular / Q000627:therapeutic use; D000995:Antitubercular Agents / Q000627:therapeutic use; D018407:Bacterial Physiological Phenomena; D005260:Female; D006801:Humans; D007538:Isoniazid / Q000627:therapeutic use; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000188:drug therapy; D011718:Pyrazinamide / Q000627:therapeutic use; D012293:Rifampin / Q000627:therapeutic use; D012307:Risk Factors; D014376:Tuberculosis / Q000175:diagnosis* / Q000503:physiopathology
D000904:Antibiotics, Antitubercular; D000995:Antitubercular Agents; D011718:Pyrazinamide; D007538:Isoniazid; D012293:Rifampin